Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05260333 · ClinicalTrials.gov registry record · NA
Sound Check-Correlation Between Transperineal and Digital Cervical Exam in 3rd Trimester Pregnancy
A NA study of Cervix; Pregnancy, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05260333: Completed NA study of Cervix; Pregnancy, sponsored by Baylor College of Medicine.
NCT05260333 is a NA study of Cervix; Pregnancy that has completed, run by Baylor College of Medicine. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05260333, a NA study of Cervix; Pregnancy, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to compare the accuracy of the Butterfly iQ pocket ultrasound with the digital cervical examination in the third trimester cervix. The secondary aim of this study is to compare discomfort or the two cervical exam methods and determine if patients have a preference for one over the other.
Primary Outcome
Dilation was measured on the day of the exam in centimeters. A correlation coefficient was then calculated to determine the relationship between the two exams.
Conditions Studied
Interventions
- DEVICE Butterfly iQ transperineal ultrasound exam
Study Locations (1)
Texas
- Texas Children's Hospital Pavilion for Women - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2022-07-27 |
| Phase | NA |
What the finished NCT05260333 record still lists
NCT05260333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Cervix; Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Butterfly iQ transperineal ultrasound exam is the first listed.
NCT05260333 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05260333 about?
NCT05260333 is a clinical study titled "Sound Check-Correlation Between Transperineal and Digital Cervical Exam in 3rd Trimester Pregnancy". The primary purpose of this study is to compare the accuracy of the Butterfly iQ pocket ultrasound with the digital cervical examination in the third trimester cervix. The secondary aim of this study is to compare discomfort or the two cervical exam methods and determine if patients have a preferenc...
What is the current status of trial NCT05260333?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-04-01. Estimated completion is 2022-07-27.
What conditions does trial NCT05260333 study?
This clinical trial studies the following conditions: Cervix; Pregnancy.
What interventions are being tested in trial NCT05260333?
The interventions under investigation include: Butterfly iQ transperineal ultrasound exam (DEVICE).
Who is sponsoring clinical trial NCT05260333?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05260333 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervix; Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05260333's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI